RxDoctor Payments Data

Mark Juska, MD

Pain Medicine · Muskegon, MINPI 1942439567

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,376 of the $7,281 with a category attached, or 60.1%. 33 manufacturers reported payments, led by Arthrex at 33.3% of the total. Reporting peaked in 2019 at $3,603 and has fallen 76.8% since, to $834 in 2025.

$7,281in general payments, 2019–2025

Across 224 payments — averaging $32.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Abbott$1K
  • Nevro Corp.$566
  • Medwest Associates$363
  • Boston Scientific$289
  • Spinal Simplicity, LLC$243
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$5538%
  • Food & beverage$4,37660%
  • Education$2,35232%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,281 in reported general payments places this provider in the 75th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$138,098
Medicare patients
290
Services billed
6,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen946$16,247
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen260$6,380
Tramadol Hcl ErTramadol Hcl81$4,425
Morphine Sulfate ErMorphine Sulfate213$4,225
Gabapentin328$3,806
Fentanyl40$2,674
Pregabalin154$1,796
Lubiprostone11$1,346
Methadone Hcl97$1,313
Naloxone Hcl15$1,220
Duloxetine Hcl44$970
Cyclobenzaprine Hcl101$847
Tizanidine Hcl129$829
Topiramate69$605
Baclofen58$552

Paid to pharmacies, not to this prescriber.

Other pain medicine in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →